Description
PT-141 (Bremelanotide)
Research Applications: PT-141 is a melanocortin receptor agonist extensively studied in laboratory research for its interactions with specific neuroendocrine pathways. Researchers investigate this peptide in controlled academic environments to explore its effects on various physiological signaling mechanisms. The compound has been the subject of ongoing in vitro and animal model studies examining its interactions with specific receptor systems.
Mechanism: In research settings, PT-141 is studied for its potential interactions with melanocortin receptors involved in various physiological pathways. Laboratory investigations suggest it may modulate specific signaling cascades through receptor-mediated mechanisms. Researchers continue to explore its detailed effects through controlled experimental approaches.
Technical Specifications:
- Purity: 99%
- Molecular Weight: 1545.7
- Form: Lyophilized Powder
- Storage: 2-8°C, protect from light
For Research Use Only This product is intended for laboratory and research purposes exclusively. Not intended for human consumption.